Botulinum neurotoxin type a exposure and executive functioning: A multinational web-based survey
DARU Journal of Pharmaceutical Sciences · 12.11.2026 · 35 (1)
DOI: 10.1007/s40199-026-00681-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 12.11.2026. Verfasst von Fallah Hashemi und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health Engineering, Student Research Committee, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran, Is…. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Executive Function. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Botulinum neurotoxin A (BoNT-A) injections have revolutionized both cosmetic and therapeutic interventions, gaining recognition for their positive physical and psychological effects. However, potential psychological correlates and safety concerns have received comparatively less attention. METHODOLOGY: This cross-sectional study aimed to evaluate the association between BoNT-A exposure and executive function (EF) in a global sample. We collected data from participants across 155 countries using an online survey translated into 28 languages and distributed via web-based platforms. Chi-square tests and Analysis of Variance (ANOVA) were employed to assess bivariate associations, while multivariable linear regression models using Generalized Estimating Equations (GEE) were employed to examine the association between BoNT-A exposure and EF scores, accounting for within-country clustering across the 155 countries while adjusting for sociodemographic and behavioral confounders. RESULTS: A total of 46,611 participants were screened, of whom 1,088 were excluded based on predefined criteria, leaving a primary eligible analytic cohort of N = 45,523. Among BoNT-A recipients, Self-Organization/Problem-Solving deficit scores varied significantly by injection frequency (p = 0.008), with the annual-injection group reporting a slightly higher mean score (42.3 ± 12.9), indicating a higher level of reported difficulties in this domain compared to other groups. However, the magnitude of this difference was small. No, clinically or statistically significant differences were observed across the remaining four executive function subscales (p > 0.05). In adjusted multivariable linear regression analysis controlling for sociodemographic and behavioral factors, BoNT-A injection was very small, albeit statistically significant, positive associations with higher scores for Self-Control/Inhibition (β = 0.508, 95% CI: 0.131-0.886, p = 0.008), self-regulation of emotion (β = 0.508, 95% CI: 0.238-0.778, p < 0.001), and Self-Motivation (β = 0.226, 95% CI: 0.023-0.428, p = 0.028), whereas no significant association was observed with Self-Organization/Problem-Solving, and self-management of time. Sensitivity analyses yielded a largely similar pattern across most domains but showed attenuation and loss of statistical significance for the Self-Organization/Problem-Solving association, highlighting domain-specific variability and the modest magnitude of the original estimate. CONCLUSION: These cross-sectional findings identify subtle, domain-specific observational associations. Because the Self-Organization/Problem-Solving association was attenuated in sensitivity analyses and residual confounding by indication is possible, these results should not be interpreted as evidence of toxin-induced neurocognitive changes or a causal effect. Prospective longitudinal cohort studies that incorporate comprehensive assessments of clinical indications and other potential confounders are warranted to further investigate these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental Health Engineering, Student Research Committee, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of.
- St. George's University, Saint George's, Grenada.
- Department of Environmental Health Engineering, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of. h_hashemi@sums.ac.ir.
- Department of Medicine, O.O.Bogomolets National Medical University, Kyiv, Ukraine.
- University of Sarajevo-Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina.
- Department of Environmental Health, Center for Public Health, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Lori Hoepner, Taqi Mohammed Jwad Taher, Irin Hossain, Sima Afrashteh, Hadya Abboud Abdel Fattah, Antoniya Dimova, Zaruhi Kalikyan, Ayça Demir Yıldırım, Dhuha Y Wazqar, Niguse Tadele, Juliana Faquim, Carmen Gloria Narvaez Carrasco, Anita Dewi Moelyaningrum, Mohammed Faris Abdulghani, Shaymaa Abdullateef Alfadul, Roland Badu, Agnieszka Wojtecka
Zitieren
APA
Hashemi, F., Hoepner, L., Hashemi, H., Hamidinejad, F. S., Omeragic, E., Haluza, D., Taher, T. M. J., Al-Salihy, S. R., Al-Fayyadh, S., Lalo, R., Guo, C., Hossain, I., Soltani, E., Fouly, H. A. A., Kurniasari, F., Stanciu, G., Afrashteh, S., Saridi, M., Khalaf, A., …, & Motiño, W. C. V. (2026). Botulinum neurotoxin type a exposure and executive functioning: A multinational web-based survey. DARU Journal of Pharmaceutical Sciences, 35(1). https://doi.org/10.1007/s40199-026-00681-3
Vancouver
Hashemi F, Hoepner L, Hashemi H, Hamidinejad FS, Omeragic E, Haluza D, et al. Botulinum neurotoxin type a exposure and executive functioning: A multinational web-based survey. DARU Journal of Pharmaceutical Sciences. 2026;35(1). doi:10.1007/s40199-026-00681-3
BibTeX
@article{Hashemi2026,
author = {Hashemi, Fallah and Hoepner, Lori and Hashemi, Hassan and Hamidinejad, Farahnaz Soleimani and Omeragic, Elma and Haluza, Daniela and Taher, Taqi Mohammed Jwad and Al-Salihy, Shaimaa Rahem and Al-Fayyadh, Sadeq and Lalo, Rezarta and Guo, Cui and Hossain, Irin and Soltani, Esmail and Fouly, Howieda Ahmed A and Kurniasari, Fitri and Stanciu, Gabriela and Afrashteh, Sima and Saridi, Maria and Khalaf, Atika and Fattah, Hadya Abboud Abdel and Dimova, Antoniya and Dimitrova, Zhenya and Kalikyan, Zaruhi and Caminada, Susanna and Yıldırım, Ayça Demir and Iqbal, Sehar and Wazqar, Dhuha Y and Toska, Aikaterini and Tadele, Niguse and Bouadil, Oumayma and Faquim, Juliana and Nasibova, Tohfa and Azimi, Shamila and Kartashova, Maria and Carrasco, Carmen Gloria Narvaez and Moelyaningrum, Anita Dewi and Ahmed, Elhusseiny and Abdulghani, Mohammed Faris and Naser, Salsabeel A and Ali, Zahraa Hussein and Yousif, Sahar Yaqoob and Bzeipez, Roaa Kareem and Assist, Zaidoon H Jabbar and Al-Khaqani, Mustafa and Alfadul, Shaymaa Abdullateef and Imamovic, Belma and Luvsan, Munkh-Erdene and Pandey, Apsara and Nai, Saraswoti and Xu, Huadong and Cuba, Magalys Lopez and Badu, Roland and Aldeeb, Maya Arfan and Hod, Rozita and Stanišić, Svetlana and Mihaylova, Anna and Kadhim, Taisir A and Wojtecka, Agnieszka and Podwiak, Filip and Motiño, Wendy Carolina Valladares},
title = {Botulinum neurotoxin type a exposure and executive functioning: A multinational web-based survey},
journal = {DARU Journal of Pharmaceutical Sciences},
year = {2026},
volume = {35},
number = {1},
doi = {10.1007/s40199-026-00681-3}
}
EUVIMED